Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

BACKGROUND: In 2001, it was postulated that tumour-derived exosomes could be a potent source of tumour-associated antigens (TAA). Since then, much knowledge is gained on their role in tumorigenesis but only very recently tumour-derived exosomes were used in dendritic cell (DC)-based immunotherapy. F...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Mahaweni, Niken M., Kaijen-Lambers, Margaretha E.H., Dekkers, Jacqueline, Aerts, Joachim G.J.V., Hegmans, Joost P.J.J.
التنسيق: Artigo
اللغة:Inglês
منشور في: Co-Action Publishing 2013
الموضوعات:
Short Communication
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3823268/
https://ncbi.nlm.nih.gov/pubmed/24223258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jev.v2i0.22492
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة